Wolfgang Bohm

Title: Wolfgang Bohm: Innovator in Immunological Solutions

Introduction

Wolfgang Bohm is a notable inventor based in Munich, Germany. He has made significant contributions to the field of immunology, particularly in the area of organ transplantation. With a total of 2 patents, his work focuses on preventing immunological rejection of transplanted organs.

Latest Patents

One of Wolfgang Bohm's latest patents is titled "Ameliorating immunological rejection of allograft." This invention provides a method to prevent or ameliorate hyperacute or acute rejection of a human donor organ transplanted to a human recipient. Hyperacute rejection typically occurs when a recipient has preformed anti-HLA antibodies against the transplanted organ. The method involves passing the recipient's plasma over a sterile and pyrogen-free column coupled to anti-human immunoglobulin antibodies, which effectively removes a significant portion of the immunoglobulin from the plasma.

Another significant patent is related to "Sterile and pyrogen-free columns containing coupled protein for binding." This method outlines the production of a sterile and pyrogen-free column that can remove predetermined substances from human blood. The process ensures that sterile and pyrogen-free raw materials are used at each production step, resulting in a pathogen-free, purified solution of protein that binds to substances such as LDL or immunoglobulin.

Career Highlights

Wolfgang Bohm has worked with several companies throughout his career, including Plasmaselect GmbH and Therasorb Medizinische Systeme GmbH. His expertise in immunology and innovative approaches to organ transplantation have made him a valuable asset in the medical field.

Collaborations

Wolfgang has collaborated with notable coworkers such as Jutta Muller-Derlich and Reiner Spaethe. Their combined efforts have contributed to advancements in immunological research and applications.

Conclusion

Wolfgang Bohm's innovative work in immunology, particularly in organ transplantation, showcases his dedication to improving medical outcomes. His patents reflect a commitment to advancing the field and providing solutions to complex medical challenges.